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Examples of psychiatric disorders with high heritability and a wide gap
between h2n and h2g are schizophrenia (Sullivan et al., 2003; Loh et al.,
2015) and bipolar disorder (Barnett and Smoller, 2009; Moser et al.,
2015). This observation suggests that SDD may overlap with major psy-
chiatric disorders different from MDD, since negative symptoms of
schizophrenia may resemble depression and major depression is theMajor depressive disorder (MDD) is a high-prevalence disease (~15%)
that is the ﬁfth leading disease contributing to disability-adjusted life
years (DALYs) in the US (Murray et al., 2013). The pathogenesis of MDD
is still partially unknown, consequently diagnosis is based on clinical
criteria. However, MDD is a clinically heterogeneous disorder and this
probably reﬂects heterogeneity in the underlying biology. Since
~20 years, genetic variants are known to be involved in MDD biology
thanks to family studies (Sullivan et al., 2000) and recently genome-
wide association studies (GWAS) (Hyde et al., 2016). The estimation of
genetic variants contribution and the identiﬁcation of speciﬁc variants in-
volved have been difﬁcult partly because of the heterogeneity and high
prevalence of MDD (Gratten et al., 2014). The consequent large sample
sizes required to provide adequate statistical power are difﬁcult to recruit
and self-declared depression (SDD) is an interesting option to face this
issue.
The studyby (Zeng et al., 2016)used a family-based cohort to estimate
the contribution of genetic and environmental factors to MDD and SDD.
This study suggested that common genetic variants (h2g), pedigree asso-
ciated variants (h2p) and common environmental effect shared by cou-
ples (e2c) are the major contributors to both MDD and SDD. The
proportion of total additive genetic determinant (h2n) was 30% for MDD
and 72% for SDD when environmental effects were also considered in
the model. The former ﬁnding is in line with other studies (e.g. 37% in
(Sullivan et al., 2000)) while for the latter there are not comparable
data in literature. This study proposed a framework for comparing pheno-
typically related traits but replication is pivotal. In particular, the high dif-
ference between the estimated h2n for MDD and SDD requires further
consideration since no clear biological explanation can be hypothesized.
Despite the relative contribution of h2p to MDD (20%) and SDD (50%) is
similar (i.e. ~1/3 of h2n), the high absolute contribution of rare variantsom.2016.11.003.
. This is an open access article underto SDD also needs clariﬁcation of the underlying biological mechanisms.
phase of bipolar disorder with the highest personal impact. It should be
kept in mind that the high correlation among the matrices representing
h2g, h2p and the environmental components and/or assortative mating
mayhave inﬂuenced the results in a relatively limited sample size. Results
found for SDDmay have been inﬂuenced to a larger extent by these pos-
sible sources of bias since the total variance explained for this trait was
very high (98%, SE = 9%), despite no evidence of genetic relatedness
was found analyzing genome-wide data and evidence of collinearity be-
tween the model components was similar between SDD and MDD.
For both MDD and SDD the contribution of rare variants ﬁnds poor
support in literature since previous studies were mainly focused on
common variants (e.g. (Gratten et al., 2014; Hyde et al., 2016)). Recent
and not replicated evidence supported that rare variants in the PHF21B
gene (Wong et al., 2016), in the CAV2-adaptor gene set and a network
involved in actin polymerization and dendritic spine formation
(Pirooznia et al., 2016) may be over-represented in MDD.
The contribution of common variants toMDD variance was estimated
to be 21% (SE = 2%) in a meta-analysis of nine cohorts including 9381
cases (Cross-Disorder Group of the Psychiatric Genomics et al., 2013),
that is quite higher than h2g found by Zeng et al. (10%, SE = 5%). This
maybe explainedby the relatively lowgenetic correlation across different
MDD samples (Gratten et al., 2014), as conﬁrmed by a recent meta-anal-
ysis (Hyde et al., 2016) that included ~120K subjectswithMDDor self-re-
ported depression (23andMe sample) and foundheritabilitywas 5% or 6%
depending on the considered population prevalence (15% and 25%, re-
spectively). The heritability score estimated in the 23andMe cohort was
also low (4%).
Previous family-based studies did not take into account e2c but the
overall evidence suggested that shared environment between twins did
not contribute to MDD (Sullivan et al., 2000) in line with Zeng et al. that
did not identify any effect of shared environment between siblings or
family members. On the other hand, individual-speciﬁc environmental
factors were found to affect signiﬁcantly MDD (63%, 95% CI = 58–67%
(Sullivan et al., 2000)) but this association could not be investigated by
Zeng et al. because these data were lacking.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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environmental factors contributing toMDD and SDD. Zeng et al. report-
ed that there was a high correlation between the common genetic var-
iants involved in the two phenotypes, while moderate correlation was
found for pedigree-associated variants and environmental factors com-
mon to the couple (1, 0.57 and 0.52, respectively). These estimations
need replication in independent samples since there are not similar
data in previous literature. If replicated, theymay have relevant implica-
tions for future studies in both the genetic and epidemiological ﬁelds
since SDD may become a validated proxy of MDD. On the clinical
level, the good correlation between the two phenotypes may reﬂect a
good level of psychoeducation, thus patients' better insight of disease.
It is worth of note that this can vary in different clinical settings or coun-
tries and SDD might include sub-threshold forms of depression or
(para)-physiological stress responses.
In conclusion, the study by Zeng et al. was the ﬁrst to estimate the
contribution of common genetic variants, pedigree associated variants
and different environmental factors to both MDD and SDD. The results
need replication in independent samples before any deﬁnitive state-
ment, particularly the effect of pedigree-associated variants and envi-
ronmental effects shared by couples. The high correlation between
common genetic variants involved in MDD and SDD suggested that
SDD may serve as adequate proxy of MDD in future studies.
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